Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its stake in Teladoc Health, Inc. (NYSE:TDOC) by 22.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 686,440 shares of the health services provider’s stock after selling 202,586 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.40% of Teladoc Health worth $6,302,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of TDOC. Rubric Capital Management LP acquired a new position in Teladoc Health in the second quarter valued at $45,267,000. Point72 Asset Management L.P. boosted its stake in Teladoc Health by 221.9% in the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock valued at $51,865,000 after acquiring an additional 3,655,436 shares in the last quarter. Clearline Capital LP boosted its stake in shares of Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after buying an additional 3,483,665 shares during the period. Assenagon Asset Management S.A. acquired a new stake in shares of Teladoc Health during the third quarter worth about $15,801,000. Finally, Mizuho Markets Americas LLC purchased a new position in Teladoc Health during the second quarter worth about $3,937,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Insiders Place Their Bets

In related news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the purchase, the director now directly owns 39,077 shares in the company, valued at $300,502.13. The trade was a 11.40 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.95% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Evercore ISI increased their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. The Goldman Sachs Group began coverage on shares of Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 price target on the stock. Jefferies Financial Group raised their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $10.00 price objective on shares of Teladoc Health in a report on Tuesday, August 20th. Finally, TD Cowen cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $12.24.

Teladoc Health Trading Down 0.8 %

Teladoc Health stock opened at $10.61 on Wednesday. Teladoc Health, Inc. has a 12-month low of $6.76 and a 12-month high of $22.54. The stock has a market capitalization of $1.83 billion, a PE ratio of -1.84 and a beta of 0.97. The firm has a 50 day simple moving average of $9.70 and a 200-day simple moving average of $9.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.